BioMimetic Therapeutics to Sell Remaining Dental Business for Additional $40 Million Cash plus Continuation of Royalties; Company to Focus on Orthopedics, Spine and Sports Medicine
Dec. 17, 2007
|
|
|
BioMimetic Therapeutics Reports Positive Clinical Results for GEM OS®1 in Canadian Foot and Ankle Fusion Study; Clinical Success Rate of 90% Achieved in a High Risk Patient Population
Dec. 13, 2007
|
|
|
BioMimetic Therapeutics to Provide Results for GEM OS®1 Canadian Foot and Ankle Fusion Study; Company to host Conference Call on December 13 to Discuss Study Findings
Dec. 12, 2007
|
|
|
BioMimetic Therapeutics Reports 2007 Third Quarter Results
Nov. 13, 2007
|
|
|
BioMimetic Therapeutics to Report 2007 Third Quarter Financial Results on November 13
Nov. 8, 2007
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
Nov. 5, 2007
|
|
|
BioMimetic Therapeutics' Study to Receive Award for Outstanding Publication from American Academy of Periodontology
Oct. 30, 2007
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at BIO InvestorForum 2007
Oct. 5, 2007
|
|
|
BioMimetic Therapeutics Reports 2007 Second Quarter Results
Aug. 14, 2007
|
|
|
BioMimetic Therapeutics to Report 2007 Second Quarter Financial Results on August 14
Aug. 9, 2007
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at Canaccord Adams' 27th Annual Global Growth Conference
Aug. 7, 2007
|
|
|
BioMimetic Therapeutics' Clinical Investigator Presents
Positive Interim Data on U.S. and Canadian Foot and Ankle Clinical Trials
July 13, 2007
|
|
|
BioMimetic Therapeutics' Clinical Investigator to Present Update of Orthopedic Clinical Results from U.S. and Canadian Trials; Company to host Conference Call on July 13 to Discuss Study Findings
July 10, 2007
|
|
|
BioMimetic Therapeutics Announces Highlights from Inaugural Annual Meeting of Stockholders
June 21, 2007
|
|
|
BioMimetic Therapeutics Initiates Enrollment in E.U. Registration Trial for GEM OS®1 Bone Graft; U.S. GEM OS1 Pivotal Study Protocol Amended to Allow Shorter Follow-Up Time and More Patients
June 7, 2007
|
|
|
BioMimetic Therapeutics Reports 2007 First Quarter Results; Company Added to NASDAQ Biotechnology Index
May 14, 2007
|
|
|
BioMimetic Therapeutics to Report 2007 First Quarter Financial Results on May 14
May 10, 2007
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at the Deutsche Bank 32nd Annual Health Care Conference
April 30, 2007
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at Upcoming Conference
April 4, 2007
|
|
|
BioMimetic Therapeutics Reports 2006 Fourth Quarter and Year-end Results; Company Receives Clearance to Initiate Enrollment in GEM OS1 US Pivotal Trial
March 28, 2007
|
|
|
BioMimetic Therapeutics to Report 2006 Year End Financial Results on March 28
March 22, 2007
|
|
|
BioMimetic Therapeutics Receives Orphan Drug Designation for rhPDGF-BB Treatment of Osteonecrosis of the Jaw
Feb. 21, 2007
|
|
|
BioMimetic Therapeutics, Inc. Completes Public Offering of Approximately 3.25 Million Shares of Common Stock Including the Sale of All Over-Allotment Shares
Feb. 14, 2007
|
|
|
BioMimetic Therapeutics, Inc. Announces Pricing of Public Offering
Feb. 9, 2007
|
|
|
BioMimetic Therapeutics, Inc. to Highlight Corporate Activities at Upcoming Conferences
Feb. 9, 2007
|
|
|
BioMimetic Therapeutics Reports Positive Clinical Results
Using GEM OS®1 to Treat Distal Radius Fractures
Jan. 25, 2007
|
|
|
